Today: 5 March 2026
Subscribe
Browse Category

Earnings Reports 6 February 2026

CoreWeave stock price jumps 18% as AI-spending trade rebounds; CRWV earnings date set

CoreWeave stock price jumps 18% as AI-spending trade rebounds; CRWV earnings date set

CoreWeave shares jumped 18.3% to $88.31 Friday, rebounding after two days of steep losses. Trading volume hit 27.7 million by 3 p.m. EST. The surge followed Amazon’s $200 billion data center spending plan and Nvidia’s recent $2 billion investment in CoreWeave. The company also launched its first brand campaign and unveiled a new customer testing lab.
6 February 2026
··
Impinj stock dives 24% after outlook whiffs; Evercore slashes rating on PI

Impinj stock dives 24% after outlook whiffs; Evercore slashes rating on PI

Impinj shares fell 24.3% to $116.46 Friday after the company forecast a sharp first-quarter slowdown, citing inventory burn-down in logistics and weaker systems demand. Evercore ISI downgraded the stock and cut its price target to $112. Fourth-quarter revenue came in at $92.8 million, with first-quarter guidance of $71–$74 million. The stock hit an intraday low of $105.
6 February 2026
··
Estee Lauder stock rebounds after brutal earnings selloff as Citi upgrade shifts focus to tariffs

Estee Lauder stock rebounds after brutal earnings selloff as Citi upgrade shifts focus to tariffs

Estee Lauder shares rose about 4% to $100.58 on Friday, recovering part of Thursday’s post-earnings drop. Citi upgraded the stock to “buy,” citing elevated expectations and travel retail disruptions as key factors in the selloff. The company reported fiscal Q2 net sales up 6% to $4.23 billion and reiterated a $100 million tariff hit to annual profit. U.S. demand and tariffs remain major concerns.
6 February 2026
··
VeriSign stock dives nearly 10% after outlook, costs take the shine off results

VeriSign stock dives nearly 10% after outlook, costs take the shine off results

VeriSign shares dropped nearly 10% Friday after its quarterly report, underperforming a rising market. The company raised its dividend and maintained heavy buybacks, but 2026 guidance and .com pricing limits drew scrutiny. Fourth-quarter revenue reached $425 million with net income of $206 million. Post-hearing briefs in the .web arbitration are expected in the first half of 2026.
6 February 2026
··
Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys shares dropped 12.7% to $111.62 Friday after the company forecast 2026 revenue growth of 7% to 8%, below last year’s 10%. The cybersecurity firm reported fourth-quarter revenue of $175.3 million and raised its share buyback program by $200 million. RBC and Truist trimmed price targets. CEO Sumedh Thakar received performance shares, with some withheld for taxes.
6 February 2026
···
Cisco stock pops near a fresh high as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco stock pops near a fresh high as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco shares rose 2.4% to $84.32 Friday, nearing a record high ahead of its Feb. 11 earnings report. UBS reaffirmed its Buy rating and $90 target, citing stable enterprise demand and expected revenue above $15.05 billion. Investors are watching for updates on AI-driven orders and network spending. The earnings release coincides with key U.S. jobs and inflation data.
6 February 2026
···
ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

Align Technology shares rose about 4% to $182.70 by midday Friday, following a strong earnings report and record clear-aligner shipments. The company posted Q4 revenue of $1.05 billion and non-GAAP earnings of $3.29 per share, with 676,900 cases shipped. Align forecast Q1 revenue between $1.01 billion and $1.03 billion. The stock jumped 11% in the previous session.
6 February 2026
····
AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt

AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt

AbbVie shares climbed 2% to $223.45 in midday trading Friday after a volatile week. The move followed a quarterly report showing fourth-quarter net revenues up 10% to $16.62 billion and adjusted profit of $2.71 per share. Humira sales dropped 25.9% as biosimilar competition increased, while Skyrizi and Rinvoq posted gains. The company also announced new regulatory approvals and licensing deals.
6 February 2026
···
Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials shares rose 5.7% to $321.20 by midday after Citi raised its price target to $400 and kept a Buy rating ahead of the Feb. 12 earnings report. Traders are focused on guidance for chip-factory investment and demand from China. Peers Lam Research and KLA also posted strong gains.
6 February 2026
······
IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN shares surged nearly 7% to $42.64 Friday after plunging 11% on a quarterly revenue miss. The bitcoin miner reported a $155.4 million net loss and $184.7 million revenue for the quarter, down from the previous period. IREN announced $3.6 billion in GPU financing tied to a Microsoft deal and plans for a new Oklahoma data center. Most revenue remains linked to crypto, despite the AI cloud pivot.
6 February 2026
····
Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce shares rose 0.1% to $190.07 Friday after a volatile week, but remain down 9% since Monday. The S&P 500 software and services index fell 4.6% Thursday, erasing about $1 trillion in market value since Jan. 28. Investors are concerned rapid AI adoption could disrupt traditional software revenue models. Salesforce reports earnings Feb. 25.
6 February 2026
···
Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target

Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target

Sirius XM shares fell 5.3% to $21.40 Friday after Seaport Global downgraded the stock, erasing part of Thursday’s 9% surge. The company set 2026 targets of $8.5 billion in revenue and $2.6 billion adjusted EBITDA, but subscriber losses and concerns over pricing weighed on sentiment. SiriusXM ended 2025 with 33 million subscribers and reported $8.56 billion in revenue for the year.
6 February 2026
··
Hershey stock price jumps again: HSY extends rally as 2026 outlook tops estimates

Hershey stock price jumps again: HSY extends rally as 2026 outlook tops estimates

Hershey shares rose about 3% Friday, extending gains after a strong fourth-quarter report and a 2026 outlook that topped analyst forecasts. The stock peaked at $234.01 before settling near $231.10 in morning trading. The company projected 2026 net sales growth of 4–5% and adjusted EPS of $8.20–$8.52. Hershey expects first-quarter margins to remain pressured, with improvement likely in the second quarter.
6 February 2026
··
ITT stock rises again after earnings jump; KeyBanc lifts target to $230

ITT stock rises again after earnings jump; KeyBanc lifts target to $230

ITT shares rose 0.9% to $203.82 Friday after a 9% rally Thursday, driven by strong Q4 results and a raised dividend. The company reported a 13% revenue jump to $1.054 billion and set Q1 EPS guidance at $1.67–$1.71. ITT expects to close its SPX Flow acquisition in March and will adjust profit metrics after the deal. KeyBanc raised its price target to $230.
6 February 2026
···
1 … 25 26 27 28 29 … 226
Go toTop